Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colorectal Cancer (mCRC)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01661270
What this trial is testing

Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin Chemotherapy

Who this might be right for
Colorectal Cancer Metastatic
Sanofi 332
Large-scale testing (Phase 3)Looking for participantsNCT07389265
What this trial is testing

Continuation of Cetuximab Beyond First-Line Progression in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
University of Campania Luigi Vanvitelli 480
Testing effectiveness (Phase 2)Looking for participantsNCT06149481
What this trial is testing

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Looking for participantsNCT07011576
What this trial is testing

Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)

Who this might be right for
Colon CancerRectal CancerColorectal Cancer+1 more
SCRI Development Innovations, LLC 60
Large-scale testing (Phase 3)UnknownNCT03909724
What this trial is testing

Pulsatile High-dose Sunitinib Versus TAS-102 in Patients With Metastatic Colorectal Carcinoma (mCRC)

Who this might be right for
Colorectal CancerMetastasis
Amsterdam UMC, location VUmc 60
Not applicableStudy completedNCT01533740
What this trial is testing

Circulating Regulatory Lymphocytes and Outcome of Metastatic Colorectal Cancer Patients

Who this might be right for
Metastatic Colorectal Cancer
University of Rome Tor Vergata 31
Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Ended earlyNCT05584137
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of HLX26 and Serplulimab in Patients with MCRC

Who this might be right for
Colorectal Cancer Metastatic
Shanghai Henlius Biotech 2
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Testing effectiveness (Phase 2)Study completedNCT01362361
What this trial is testing

TRICC-C (AIO-KRK-0111): BIBF 1120 Versus Placebo in Patients Receiving Oxaliplatin Plus Fluorouracil and Leucovorin (mFOLFOX6) for Advanced, Chemorefractory Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Colorectal Cancer
Martin-Luther-Universität Halle-Wittenberg 54
Not applicableLooking for participantsNCT07623174
What this trial is testing

Fruquintinib in Adults With Metastatic Colorectal Cancer in Poland

Who this might be right for
Metastatic Colorectal Cancer
Takeda 110
Not applicableStudy completedNCT06029010
What this trial is testing

An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States

Who this might be right for
Metastatic Colorectal Cancer
Bayer 2,326
Large-scale testing (Phase 3)Active Not RecruitingNCT04008030
What this trial is testing

Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
Bristol-Myers Squibb 839
Early research (Phase 1)Not Yet RecruitingNCT07543471
What this trial is testing

A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer

Who this might be right for
mCRC
Shanghai Henlius Biotech 387
Not applicableStudy completedNCT03699111
What this trial is testing

Identification of New Patient Stratification Tools in MSS RAS mt mCRC

Who this might be right for
Advanced Colorectal Cancer
Cancer Trials Ireland 29
Testing effectiveness (Phase 2)Looking for participantsNCT05962502
What this trial is testing

Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy

Who this might be right for
Metastatic Colorectal Cancer
Sun Yat-sen University 54
Not applicableStudy completedNCT01909362
What this trial is testing

Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)

Who this might be right for
Colorectal NeoplasmsAdvanced Metastatic Colorectal Cancer
US Oncology Research 52
Testing effectiveness (Phase 2)Looking for participantsNCT07012954
What this trial is testing

CtDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 64
Not applicableUnknownNCT04555369
What this trial is testing

The Value of ctDNA on Chemotherapy Efficacy for mCRC

Who this might be right for
Circulating Tumor DNA
Fudan University 300
Large-scale testing (Phase 3)Not Yet RecruitingNCT07025239
What this trial is testing

QL1706 Injection Plus Bevacizumab and XELOX vs Placebo Plus Bevacizumab and XELOX as First-Line Treatment of Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Qilu Pharmaceutical Co., Ltd. 430
Next Page